Branching morphogenesis is thought to be governed by epithelial-stromal interactions, but the mechanisms underlying specification of branch location remain largely unknown. Prompted by the striking absence of Hedgehog (Hh) response at the sites of nascent buds in regenerating tubules of the adult prostate, we investigated the role of Hh signalling in adult prostate branching morphogenesis. We find that pathway activity is localized to stromal cells, and that its attenuation by genetic or pharmacologic manipulation leads to increased branching. Decreased pathway activity correlates with increased stromal production of hepatocyte growth factor (Hgf), and we show that Hgf induces epithelial tubule branching. Regulation of Hgf expression by Hh signalling is indirect, mediated by Hh-induced expression of the microRNAs miR-26a and miR-26b, which in turn downregulate expression of Hgf. Prostate tubule branching thus may be initiated from regions of low Hh pathway activity, with implications for the prostatic hyperplasia commonly observed in late adulthood.
Epithelial-stromal interactions are crucial for normal pattern formation in embryonic organ development and for the homeostatic maintenance of organ integrity in adults. Following bacterial injury of the adult bladder, for example, Sonic hedgehog (Shh) produced in cells of the basal urothelium elicits production of secreted factors from stromal cells, which in turn stimulate proliferation and differentiation of urothelial cells. This epithelial/stromal signal feedback circuit underlies injury-induced regeneration of the urothelium and restoration of its normal function 1 .
We focus here on growth and branching of the adult prostate. Our experimental system, the mouse prostate, comprises three paired lobes-the ventral, dorsolateral and anterior lobes-each consisting of a highly branched network of ductal tubules 2 . Castration results in loss of testosterone production and consequent involution of the prostate, largely through loss of distal branches. Testosterone replacement can then induce regeneration of new distal branches 3 , thus providing a model for adult growth and branching morphogenesis.
Regenerative prostate growth in the adult differs significantly from embryonic and postnatal prostate development, as embryonic epithelium grows and invades an extensive expanse of mesenchyme that surrounds the epithelial ducts. In contrast, adult epithelial ducts are encircled by thin, dense, stromal sheaths that are in turn held together by looser interductal connective tissue 2 . The importance of understanding adult prostate regeneration is highlighted by the excessive branching and growth associated with benign prostatic hyperplasia, a condition affecting most men over 50 years of age 4 .
Much previous study of the functional role of Hh signalling in prostate growth has focused on embryonic and early postnatal development [5] [6] [7] [8] [9] [10] [11] [12] [13] with contradictory reports of inhibitory effects of Hh signalling [9] [10] [11] or of decreased branching with Hh inhibition 12, 13 , and recent support for a changing role during development 8 . These studies have been based largely on ex vivo cultures of embryonic or early postnatal prostate from mice or rats treated with recombinant proteins or drugs. These ex vivo conditions do not fully recapitulate in vivo processes, especially responses that may be specifically restricted to epithelial or stromal cells, and the physiological significance of these studies thus requires in vivo validation. A common feature of all these studies is that Hh signal response normally occurs in stromal cells during embryonic 5, 13 and early postnatal development 11 , and in adulthood 14 .
Although potential roles of Hh signalling during development have been suggested 5, 6, [8] [9] [10] [11] [12] [13] , detailed spatial information regarding Hh signal response in relation to branched outgrowth of adult prostate has not been presented. In addition, evidence from several studies suggests that there may be a shift in prevailing expression from Sonic hedgehog (Shh) in the embryo [11] [12] [13] to Indian hedgehog (Ihh) after birth 6 ; production of Hh ligands from distinctly regulated genes thus may also contribute to distinct roles for Hh signalling in embryo and adult.
RESULTS

Absence of stromal Hh response at the tips of nascent buds
Previous work showed that Hh pathway response, as determined by expression of the Hh pathway target gene Gli1, occurs only in a subset of stromal cells 14 . To visualize the three-dimensional organization of Hh response during prostate regeneration, Gli1 CreER/WT ; R26 mTmG/WT mice were castrated to cause prostate regression followed two weeks later by insertion of a testosterone pellet to induce regeneration ( Supplementary Fig. 1a ). Tamoxifen (TM) was administered three days after testosterone replacement for a period of four days to activate CreER and thus induce excision of mT (membrane-targeted tdTomato), leading to permanent marking of Gli1-expressing cells and their progeny by expression of mG (membrane-targeted EGFP).
Prostates were collected three days later and treated with a clearing solution 15 to facilitate imaging of entire prostate ducts with twophoton microscopy, thus overcoming the limited imaging depth of confocal microscopy due to photobleaching and light scattering. Three-dimensional reconstruction of the two-photon images revealed that Gli1-positive, Hh-responsive cells are entirely stromal and are arranged in bands that enwrap the prostate tubules ( Fig. 1a and Supplementary Fig. 1b and Videos 1-4). Strikingly, Hh response was conspicuously absent from stromal cells at the tips of nascent buds (best viewed in Supplementary Videos 1-4; see also Fig. 1a, b and Supplementary Fig. 1b ), but was present in stromal cells along the tubules, at branch points, or surrounding the ends of mature tubules that are not budding (Fig. 1c ). These observations suggested that stromal regions lacking Hh pathway activity may promote the formation of new prostate branches.
Reduced Hh pathway activity increases tubulogenesis
To examine the role of Hh pathway activity in branch formation during prostate regeneration, Gli1 mutant mice and wild-type (WT) littermates were subjected to castration and androgen replacement ( Fig. 2a ), and three days later prostates were collected. Each lobe was microdissected to show individual branches, which were counted and are presented as the percentage increase in branches relative to the number of tips that remain in involuted prostates. The percentage increase in branches on regeneration more than doubled in Gli1 −/− mutants relative to WT, with a 2.5-fold increase in the ventral prostate and a 2.9-fold increase in the dorsolateral prostate ( Fig. 2b) antagonist GDC-0449 (Vismodegib) beginning three days before androgen replacement and continuing throughout the duration of regeneration ( Fig. 2c and Supplementary Fig. 1c ) showed a 2.0-fold and 2.2-fold augmentation of the percentage increase in branches for the ventral and dorsolateral prostate, respectively, as compared with vehicle-treated mice ( Fig. 2d ). Cell layer specificity of Hh action was examined by administering TM to mice expressing CreER under control of the Gli1 promoter, which is active exclusively in stromal cells (see above); these mice also carried homozygous floxed alleles of the essential Hh pathway transductory component Smoothened (Smo) (Gli1 CreER/WT ; Smo flox/flox ). With TM administration before castration and testosterone replacement a similar 2.0-fold and 2.0-fold augmentation of the percentage increase in branching was observed in ventral and dorsolateral prostates respectively as compared with vehicle control mice ( Fig. 2e,f and Supplementary Fig. 1d ). Each of these three methods of Hh pathway attenuation consistently augments regenerative branching by at least 2-fold in an overall total of 60 samples and in a highly statistically significant manner. Attenuation of Hh pathway activity thus promotes branching, and the critical site of this effect is in the stromal cells that enwrap the growing tubules.
Hh pathway activity in stromal cells reduces Hgf levels
As branching morphogenesis necessarily involves the epithelium, we reasoned that the effect of stromal Hh pathway response on prostate branching is mediated by a secreted factor. We performed a microarray analysis of RNA extracted from WT or Gli1 mutant prostates after castration and 3 days of androgen replacement and found that 85 genes were upregulated by at least 1.4-fold (P < 0.01) in regenerating Gli1 mutant prostates as compared with WT. We selected genes annotated with the SP_PIR_Keyword 'signal' and 'secreted' to identify genes encoding secreted proteins involved in cell signalling ( Supplementary Table 1 ) and found Hgf as an attractive candidate for a prostate branching factor because it modulates branching of mammary gland 16, 17 , lung 18 and kidney 19 . We confirmed the microarray data by real-time PCR (rtPCR; Fig. 3a ), and found that Hgf protein levels were also significantly higher in Gli1 mutant prostates as compared with WT ( Fig. 3b) .
To investigate the cell layer specificity of gene expression we used an established fluorescence-activated cell sorting (FACS) protocol to isolate epithelial basal and luminal cells as well as stromal cells from WT prostates 20 (Fig. 3c ) and immediately subjected them to rtPCR analysis ( Fig. 3d ); stromal cell identity was confirmed by culture and staining with antibodies against vimentin and smooth muscle actin ( Fig. 3e ). As expected, Gli1 is expressed primarily in stromal cells, which is also the predominant site of Hgf expression ( Fig. 3d ). Expression of the Hgf receptor c-Met in contrast was highest in epithelial cells, predominantly the basal fraction ( Fig. 3d ).
To directly determine whether Hh pathway activity in stromal cells modulates Hgf levels, cultured stromal cells were treated with the Smo agonist, purmorphamine, or dimethylsulphoxide (DMSO) as a control (Fig. 3f ). Following 24 h of purmorphamine treatment we noted an increase in Gli1 transcripts; we also noted a corresponding decrease in levels of Hgf messenger RNA and in levels of Hgf protein secreted into the medium (Fig. 3f ). In addition, treatment with purmorphamine of NIH 3T3 cells, a mouse embryo fibroblast line known both to produce Hgf (ref. 21) and to respond to Hh signalling 22 , led to decreased activity of conditioned medium in an MDCK cell tubulogenesis assay 23, 24 ( Supplementary Fig. 2 ), consistent with a negative regulatory effect of Hh signalling on Hgf expression. Taken together, these data indicate an inhibitory relationship between Hh pathway activity and stromal levels of Hgf.
This relationship, in combination with two-photon images of regenerating prostates ( Fig. 1a and Supplementary Fig. 1b ), raises the interesting possibility that regions where stromal cells lack Hh response may correspond to regions with high levels of Hgf at the locations of new branches. To test this hypothesis, Gli1 CreER/WT ; R26 EYFP/WT mice were castrated, testosterone pellets implanted, and three days later TM was administered on four consecutive days to label Gli1-expressing cells during regeneration. Following an additional three days for completion of TM-induced recombination, prostates were collected and EYFP-positive and -negative stromal cells were isolated by FACS ( Fig. 3g ). rtPCR analyses of RNA extracted from these cells showed an increase in Gli1 and Ptch1 mRNA levels in the EYFP-positive cells ( Fig. 3g ), indicating that the population is enriched for cells that are responding to the Hh ligand. These EYFP-positive cells expressed lower levels of Hgf than EYFP-negative cells ( Fig. 3g ), suggesting that regions of low Hh response are regions of higher Hgf expression. The level of expression of the stromal marker Vimentin was unchanged between the two populations.
The difference in Gli1 mRNA between EYFP-positive and -negative stromal cells in this experiment, although clear and statistically significant, is not as great as in isolated stromal cells stimulated in vitro, possibly resulting from the 3 to 6 days between TM administration and prostate collection. During this elapsed time Hh response patterns may change as branching and maturation of the regenerating prostate tubules proceeds, leading to an underestimate of the difference in pathway activity and in Hgf expression in isolated cells as compared with the actual difference in vivo at the time of recombination and marking.
Hgf induces prostate branching
To determine whether Hgf induces prostate branching, dissociated prostate cells were cultured in vitro in three-dimensional cultures for 5 days until they formed spheres ( Fig. 4a ), after which recombinant Hgf protein was added to the media. Four days later we observed the formation of complex branched structures in Hgf-treated wells, but not in control conditions (Fig. 4b,c and Supplementary Video 5), demonstrating that Hgf acts on the prostate epithelium to induce branching morphogenesis. To investigate the possibility that Hgf induces prostate branching by stimulating cell proliferation, basal prostate epithelial cells were isolated and cultured in vitro until they formed small colonies, at which time recombinant Hgf protein was added. Two days later we found 1.9-fold more Hgf-treated cells, as compared with the control ( Supplementary Fig. 3a ), suggesting that Hgf indeed stimulates cell proliferation.
To further test whether stromal Hgf expression induces branching, we used a subrenal prostate regeneration assay, which involves engraftment of adult prostate epithelium and embryonic urogenital sinus mesenchyme (UGSM) under the kidney capsule of immunocompromised mice 20, [25] [26] [27] . UGSM cells were transduced with a bicistronic lentiviral construct for expression of Hgf, and (a) Expression of Hgf is 2.1-fold higher in Gli1 mutant compared with WT prostates after 3 days of testosterone replacement following castration. n = 3 prostates per genotype. (b) Hgf protein levels in tissue lysates prepared from regenerating prostates, normalized to total lysate protein levels. There is a 1.2-fold increase in Hgf levels in Gli1 mutant compared with WT VP (n = 5 prostates per genotype) and a 1.9-fold increase in Hgf levels in Gli1 mutant compared with WT DLP (n = 5 prostates per genotype). GFP from an internal ribosome entry site. GFP-positive UGSM cells were isolated by FACS, and combined in equal proportion with adult epithelial cells expressing membrane-tagged tdTomato (Fig. 4d ). Examination of tissue sections through these subrenal prostate grafts 8 weeks after implantation revealed a 1.9-fold greater number of tubules in grafts formed from UGSM infected with lentivirus expressing Hgf as compared with the control grafts ( Fig. 4e-g) , indicative of increased branching stimulated by increased Hgf levels.
To directly examine the role of Hgf signalling response in prostate branching, we used mice expressing CreER under control of the ubiquitously expressed Actin promoter to drive deletion of a conditional c-Met allele 28 (ActinCreER; c-Met flox/flox ); deletion of c-Met following TM administration was verified by genotyping DNA from prostate lobes ( Supplementary Fig. 3b ). ActinCreER; c-Met flox/flox or c-Met flox/flox mice were castrated, and then treated with TM after prostate regression. Testosterone pellets were implanted three days later to allow completion of TM-induced recombination, and prostates were dissected five days after that ( Fig. 5a ). As compared with control c-Met flox/flox mice, ActinCreER; c-Met flox/flox mice showed a 3.7-fold and a 3.3-fold attenuation in percentage increase in branches of ventral and dorsolateral prostate, respectively ( Fig. 5b ). These results demonstrate that reduction of Hgf response in vivo leads to markedly decreased branching morphogenesis during regeneration.
To confirm this pharmacologically, WT mice were castrated, and then treated with a c-Met inhibitor, AMG 458, before androgen replacement ( Fig. 5c ). AMG 458 is an orally bioavailable drug that is highly specific for c-Met, showing selectivity for inhibition of c-Met over a panel of tyrosine and serine/threonine kinases 29 ; we indeed noted a reduction of phosphorylated c-Met protein in drug-treated mice as compared with controls ( Supplementary  Fig. 3c ). Five days after androgen replacement, animals treated with AMG 458 showed ventral and dorsolateral prostates with 1.8-fold and 1.4-fold attenuation respectively in percentage increase in branches as compared with vehicle-treated animals (Fig. 5d ).
These in vitro and in vivo genetic and pharmacologic data together show that Hgf signalling plays a crucial role in promoting adult prostate branching.
Hh pathway downregulates Hgf through miR-26a/b
Hh and Hgf pathway activities have opposite effects on prostate branching, and Hh pathway activity is associated with decreased Hgf expression, suggesting a negative regulatory relationship between Hh activity and expression of Hgf. The Hh pathway mediator Gli1, however, functions exclusively as a transcriptional activator 30 , suggesting an indirect relationship between Gli1 and Hgf expression. To investigate whether this could occur through Hh-pathway activation of microRNA transcription, potential microRNAs that could target Hgf were identified using the TargetScanMouse 6.2 (ref. 31 ) and DIANA-microT 3.0 (refs 32,33) algorithms. Both prediction algorithms had as their top-ranked hits the paralogues miR-26a and miR-26b, which have identical seed sequences (6-8 nucleotides at the 5 end of the mature miRNA) and may target the same regions on the 3 UTR of Hgf mRNA. In addition to complementarity of the seed sequence to the Hgf 3 UTR, both miRNAs also have a supplementary site at the 3 end of the miRNA, which is complementary to the Hgf UTR and is thought to augment seed pairing 34 . Both miRNAs are predicted to target two sites on the 3 UTR of Hgf, with identical seed sequences and slightly different supplementary sequences, and both sites are highly conserved in vertebrate Hgf 3 UTRs ( Fig. 6a and Supplementary Fig. 4 ).
To determine whether miR-26a and miR-26b are able to regulate the 3 UTR of Hgf, luciferase reporter assays were used (Fig. 6b) .
The 3 UTR of Hgf was cloned into the pMir-Report vector, downstream of the luciferase gene. HEK293S cells were co-transfected with Renilla luciferase vector and the pMir-Report luciferase vector with or without the Hgf 3 UTR, and with mature miR-26a or miR-26b mimics, which are chemically modified double-stranded RNAs that mimic endogenous mature miRNAs. Co-transfection of miR-26a or miR-26b mimics suppressed the luciferase activity of the vector with the Hgf 3 UTR by 45% and 30% respectively compared with a negative control scrambled mimic, but did not change the luciferase levels of the control vector ( Fig. 6c ). Mutation of the seed region in both sites of the Hgf 3 UTR abrogated the repressive effect of the miRNA mimics, demonstrating the specificity of the miRNA mimics for Hgf (Fig. 6c ).
In addition to the Hgf 3 UTR, the ability of miR-26a and miR-26b to regulate endogenous Hgf mRNA and protein levels in prostate stromal cells was examined. Stromal cells were isolated from WT mouse prostates by FACS and cultured in vitro, transfected with miRNA mimics, and Hgf mRNA and protein levels were determined (Fig. 6d ). Transfection of either miR-26a or miR-26b led to a decrease in both Hgf mRNA and protein levels as compared with transfection with a scrambled miRNA mimic, demonstrating that both miRNAs are able to regulate endogenous Hgf levels in prostate cells (Fig. 6e,f) .
To investigate the possibility that Hh pathway activity reduces Hgf levels by increasing miR-26a and miR-26b expression, we treated WT prostate stromal cells with purmorphamine and found that levels of both miR-26a and miR-26b increased on purmorphamine treatment (Fig. 6g,h) . We also isolated stromal cells from regenerating prostates on the basis of their status of Hh pathway response, by isolating EYFPpositive and EYFP-negative cells from regenerating Gli1 CreER/WT ; R26 EYFP/WT prostates (Fig. 3g ). EYFP expression indicates response to Hh ligand (Fig. 3g) , and we find that these cells also express increased levels of miR-26a and miR-26b ( Fig. 6i ) and decreased levels of Hgf (Fig. 3g) , providing further evidence that Hh pathway activity downregulates Hgf levels through miR-26a and miR-26b.
Ihh expression patterns stromal Hh response
To determine whether expression of Gli1 in a restricted subset of stromal cells results from differential response to the Hh ligand within stromal cells or, alternatively, from restricted Hh ligand expression in epithelial cells, we isolated Gli1-positive and -negative cells from Gli1 CreER/WT ; R26 EYFP/WT mice that were given TM. EYFP-positive and -negative prostate stromal cells were isolated by FACS, cultured separately in vitro, stimulated with purmorphamine, and levels of Gli1 transcript were measured by rtPCR ( Supplementary Fig. 5a ). We found that both EYFP-positive and -negative cells responded to purmorphamine by upregulating Gli1 expression to similar extents ( Supplementary Fig. 5b ), indicating that all stromal cells retain an equivalent capacity to respond to Hh pathway stimulation, and suggesting possible differences in Hh ligand expression.
Although it was shown that basal cells at the proximal end of the prostate dorsal lobe express Shh (ref. 14) , others have shown that Shh expression in the prostate is greatly downregulated after birth 11, 13 , whereas Ihh expression persists 6 . Our own rtPCR analyses of Shh and Ihh mRNA levels in RNA extracted from embryonic (E15.5), early post-natal (P2) and adult ventral and dorsolateral prostate lobes showed that, during development, Shh mRNA levels progressively declined ∼10-fold relative to internal controls whereas Ihh mRNA levels progressively increased by ∼12-fold. The ∼120-fold change in the relative abundance of Ihh mRNA as compared with Shh mRNA from embryo to adult suggests that their relative importance as ligands may shift during development ( Fig. 7a and Supplementary Fig. 5c ). Indeed, we examined prostates of TM-treated Shh CreER/WT ; R26 mTmG/WT (ref. 35 ) mouse adults and did not detect expression of Shh in the distal regions ( Supplementary Fig. 5e ). Primary adult prostate stromal cells in culture respond to recombinant Ihh protein by upregulating expression of Gli1, miR-26a and miR-26b, and downregulating Hgf expression ( Supplementary Fig. 5d ), and the increased levels of adult Ihh expression and the prominence of distal prostate in adult regenerative branching morphogenesis together suggest that Ihh may play an important role in patterning Hh pathway response in the stroma, thereby controlling the local levels of stromal Hgf expression.
To determine whether the pattern of Ihh expression in the prostate is similar to the pattern of Gli1 expression, we generated an Ihh CreER mouse with CreER knocked into the endogenous Ihh locus (Supplementary Fig. 6 ). TM was administered to Ihh CreER/WT ; R26 mTmG/WT and Gli1 CreER/WT ; R26 mTmG/WT mice, and prostates were collected after five days. Examination of tissue sections from Gli1 CreER/WT ; R26 mTmG/WT prostates showed ductal regions wholly or partially surrounded by stromal cells that are Gli1-positive and thus are responding to Hh ligand, but also ductal regions surrounded by Gli1-negative stromal cells (Fig. 7b ). Tissue sections from Ihh CreER/WT ; R26 mTmG/WT prostates revealed similar patterns of Ihh expression in the epithelium, with some regions entirely or partially Ihh-positive, as well as other regions entirely devoid of Ihh expression. These similarities suggest that the pattern of Gli1 expression in prostate stroma could be accounted for by the pattern of Ihh expression (Fig. 7b ). The regional differences in Ihh CreER -driven marking are not likely due to incomplete Cre recombination as the dose and duration of TM treatment, when administered to ActinCreER; R26 mTmG/WT mice, induced almost 100% recombination in epithelial cells (Fig. 7b ).
DISCUSSION
In this study we find that Hh response in regenerating prostate is present in the stromal cells that enwrap prostate tubules, but is conspicuously absent from stromal cells at the sites of nascent tubule buds. These stromal cells lacking Hh response express higher levels of Hgf than Hh-responsive stromal cells, an effect probably mediated by Hh induction of miR-26a and miR-26b. We find that Hgf stimulates prostate branching, thus providing a link between reduced Hh response in specific regions of the stroma and the sites of epithelial branching. Finally, we find that the spatial pattern of Hh signal response in stromal cells is strikingly similar to the pattern of Ihh expression in the epithelium, suggesting that the location of nascent buds during adult prostate branching morphogenesis is specified by spatially restricted Hh signalling from epithelium to stroma.
Our data suggest a model (Fig. 8a ) in which regional differences in Hh ligand secretion and pathway response determine the location of a nascent bud during adult branching morphogenesis. Thus, in epithelial regions of high Ihh expression, Hh response in adjacent stromal cells downregulates stromal expression of Hgf by inducing expression of miR-26a and miR-26b ( Fig. 8b ), leading to low concentrations of Hgf ligand and a consequent lack of branching. Regions of low epithelial Ihh ligand expression in contrast would be associated with low Hh response in adjacent stromal cells, permitting high levels of Hgf secretion that could stimulate formation of nascent buds.
Although a branched structure is essential for normal prostate function, the occurrence of excessive branching in adulthood is associated with benign prostatic hyperplasia (BPH), a disease that affects 50% of men in their 50s and increases progressively to 90% of men in their 80s (ref. 4) . BPH is characterized by an increase in nodules in the transition zone of the human prostate due to excessive ductal budding and branching [36] [37] [38] [39] . At present, there are two generally accepted permissive factors for the pathogenesis of BPH, the presence of circulating androgens and increasing age 40 , but the underlying molecular mechanisms remain poorly understood.
The epithelial-stromal interaction described here seems likely to operate in human prostate, as SHH ligand expression in the normal human prostate is localized to the epithelium, whereas pathway response, as determined by Gli1 expression, is localized to the stroma 41 . C-MET expression is localized to the basal cells in both normal human transition zone and in BPH samples 42 , and cultured prostate stromal cells in vitro secrete HGF (ref. 43 ). The HH/HGF circuit we describe thus might be involved in driving the abnormal prostate growth observed in BPH; alternatively, this circuit may simply operate to pattern the branching in the context of growth that is driven by other factors. In either case, manipulation of this epithelial/stromal feedback circuit could prove therapeutically useful.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3057 METHODS Mice. Male mice between 8 and 10 weeks of age were used for all experiments.
Gli1 LacZ/WT heterozygotes 44 from our colony were back-crossed for 10 generations to the FVB strain, and then interbred to generate Gli1 LacZ/LacZ homozygotes. WT littermates were used as controls. Gli1 CreER/WT mice 45 were crossed with R26 EYFP/EYFP mice 46 or R26 mTmG/mTmG mice 47 or Smo flox/flox mice 48 to obtain Gli1 CreER/WT ; R26 EYFP/WT or Gli1 CreER/WT ; R26 mTmG/WT or Gli1 CreER/WT ; Smo flox/WT mice. Resulting mice were crossed with Smo flox/flox mice to obtain Gli1 CreER/WT ; Smo flox/flox mice. All mouse strains except as otherwise indicated were obtained from Jackson Laboratories. All castration and testosterone implantation procedures were performed under isoflurane anaesthesia, which was administered in a fume hood with a standard vaporizer (J. B. Baulch and Associates). To induce CreER-mediated recombination in mice harbouring the CreER allele, tamoxifen (Sigma, 12 mg per 30 g body weight) was administered by oral gavage. For each experiment, no statistical method was used to predetermine sample size, and mice in each cage were randomly selected for drug/tamoxifen or control treatments. The investigators were blinded to allocation during experiments and outcome assessment. Counting of prostate tubules was blinded to ensure that the investigator who assessed the tissues did not know which treatment group each sample belonged to. All procedures were performed under a protocol approved by the Administrative Panel on Laboratory Animal Care at Stanford University. In all experiments, only the ventral and dorsolateral lobes of the prostate were analysed.
Castration and testosterone replacement. Castration was performed by ligation
of the spermatic cord and complete removal of the testes and epididymides through a scrotal approach. Fourteen days after castration, a pellet of testosterone (Innovative Research of America, SA-151, 10 mg) was implanted subcutaneously in the back of the mouse.
Two-photon imaging. Gli1 CreER/WT ; R26 mTmG/WT mice were castrated and testosterone replaced after 2 weeks. Three days after testosterone replacement, tamoxifen (Sigma, 12 mg per 30 g body weight) was administered by oral gavage daily for 4 consecutive days. Three days after the last dose, individual prostate lobes were dissected, fixed in 4% paraformaldehyde for 24 h, washed twice in PBS and incubated in ScaleA2 solution containing 4 M urea, 10% (wt/vol) glycerol and 0.1% (wt/vol) Triton X-100 (ref. 15 ) for 2 weeks at 4 • C. Images were captured using the Prairie Ultima IV upright two-photon microscope. Three-dimensional reconstructions of two-photon images were generated using Imaris software (Bitplane Scientific Software).
Branching analysis.
Individual prostate lobes were dissected in PBS and incubated in 1% collagenase (Sigma C6885) for 15 min at room temperature with gentle agitation. After rinsing in PBS, individual branches of each lobe were separated using fine forceps, and images were captured using a Leica M205 FA Stereomicroscope. The number of branch tips in each lobe was counted manually. The difference between the number of branches in a regenerating prostate lobe and the average number of branches in a pool of regressed prostate lobe from equivalent mice (giving the number of new branches) was divided by the number of branches in the regressed lobe and expressed as a percentage increase in the number of new branches. All prostate regeneration experiments involving branching analyses were performed on pairs of mice (control and treatment/mutant) with the same protocol on the same day to reduce variability. Pairs of mice were castrated on the same day, in the same manner, and the prostates allowed to regress. After 2 weeks, testosterone pellets were implanted subcutaneously on the same day for each pair of mice, and the prostates were collected and analysed together on the same day.
Microarray analysis. Gli1
LacZ/LacZ and WT littermates were castrated and testosterone replaced after 2 weeks. Three days after testosterone replacement, the mice were euthanized, prostate lobes were collected, and total RNA was prepared using the RNeasy Plus Mini Kit (Qiagen). RNA quality was evaluated using the Agilent 2100 Bioanalyzer system. Samples were hybridized to the Affymetrix GeneChip Mouse Exon 1.0 ST microarray chips. Three mice of each genotype were analysed. After hybridization, expression values were normalized using the RMA function in the Partek Genomics Suite software. Differentially expressed genes were identified using ANOVA, and genes showing a fold change greater or equal to 1.4 with P value < 0.01 were shortlisted for functional annotation analyses. Examination of Swiss-Prot (SP) and Protein Information Resource (PIR) Keywords (SP_PIR_KEYWORDS) was performed using DAVID (ref. 49; http://david.abcc. ncifcrf.gov/). Expression changes detected by microarray analysis were validated using quantitative rtPCR.
Database accession number.
The microarray data set is available in the GEO database (GEO accession: GSE59849).
AMG 458 treatment. FVB mice were castrated. After 13 days, a 30 mg kg −1 of body weight dose of AMG 458 in HPMCT (2% hydroxypropylmethylcellulose, 1% Tween-80 in water, adjusted to pH 2.2 with HCl) or vehicle alone was administered by oral gavage 29 . A dose of AMG 458 or vehicle was administered 12 h and 24 h later. Six hours after the third dose, a testosterone pellet was implanted subcutaneously and the fourth dose was administered 6 h later. AMG 458 or vehicle alone was administered twice daily for 5 d after testosterone implantation. Prostates were collected 3 h after the last dose, and processed for branching analyses. For protein extraction, a portion of the left lobe of the liver was removed, homogenized in RIPA buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% Triton-X 100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EGTA) with Halt Protease and Phosphatase Inhibitor Cocktail (Pierce 78440), incubated at 4 • C for 30 min, centrifuged at 10,000g for 30 min and the supernatant removed. Fifteen micrograms of total protein was loaded into each lane for SDS-PAGE and western blotting with a rabbit anti-phospho-c-Met antibody (Invitrogen 44888G, 1:1,000) or mouse anti-β-tubulin (Sigma T8660, 1:1,000) antibody. Densitometric analysis of western blot bands was performed using ImageJ software (NIH).
GDC-0449 treatment. FVB mice were castrated. After 11 days, a 100 mg kg −1 of body weight dose of GDC-0449 in MCT (0.5% methylcellulose, 0.2% Tween-80; ref. 50) or vehicle only control was administered by oral gavage twice a day for 3 d. Six hours after the last dose, testosterone was implanted subcutaneously, and GDC-0449 or vehicle was administered 6 h later, and then twice daily for 3 d after testosterone implantation. Prostates were collected 3 h after the last dose. For each paired lobe of the prostate, one lobe was processed for branching analyses and the other was homogenized for RNA extraction.
Immunofluorescence analysis of tissue sections. Individual prostate lobes were dissected in PBS, fixed in 4% paraformaldehyde for 6 h, washed 3 times in PBS, incubated in 30% sucrose overnight, and then embedded and snap-frozen in OCT compound (Tissue-tek). Twelve-micrometre sections were obtained using a Leica cryostat. For immunostaining, tissue sections were rinsed in PBS twice, then blocked in 10% goat serum in PBS containing 2% BSA and 0.25% Triton X-100 for 1 h, and incubated with the following primary antibodies diluted in blocking solution overnight at 4 • C in a humidified chamber: rabbit anti-GFP (Invitrogen A11122, 1:500), chicken anti-vimentin (Millipore, 1:600). Sections were washed three times with PBS containing 0.25% Triton X-100, incubated with DAPI and appropriate Alexa Fluor-conjugated secondary antibodies diluted 1:1,000 in blocking solution for 1 h at 22 • C, washed again three times, and mounted on slides with Prolong Gold mounting reagent (Invitrogen). Immunofluorescence images presented are images from one representative experiment of three.
Immunofluorescence analysis of cultured cells. Stromal cells were isolated by
FACS and plated onto 18-mm-diameter circular coverslips in 12-well plates, and fixed in 4% paraformaldehyde for 20 min. Cells were permeabilized with PBS/0.5% Triton X-100 for 3 min and nonspecific binding sites were blocked with 2% BSA in PBST (PBS with 0.5% Tween-20) for 1 h. Cells were stained with primary antibodies: chicken anti-vimentin (Millipore AB5733, 1:600) and mouse anti-smooth muscle actin (Sigma 1A4, 1:1,000) diluted in 2% BSA/PBST for 1 h at room temperature. After washing four times in PBST, cells were incubated for 1 h with appropriate Alexa Fluor 488-or 594-conjugated secondary antibodies (Invitrogen, 1:1,000) together with 1 g ml −1 of 4 ,6-diamidino-2-phenylindole (DAPI) for nuclear staining in 2% BSA/PBST. Cells were washed four times in PBST, and then mounted on slides with Prolong Gold mounting reagent (Invitrogen). Immunofluorescence images presented are images from one representative experiment of three.
Fluorescence-activated cell sorting. Prostate lobes were dissociated and stained for FACS following published methods 20 . Briefly, prostate lobes were dissected, minced and incubated at 37 • C in 10% FBS/DMEM containing 1 mg ml −1 collagenase (Gibco, cat. no. 17018-029). Further dissociation to a single-cell suspension was achieved by incubation in trypsin/0.05% EDTA (Invitrogen cat. no. 25300) for 5 min at 37 • C, followed by serially passing through 18-G and 20-G needles and filtering through a nylon mesh filter with a 40 µm pore size. Cells were stained for 20 min at 4 • C. Antibodies used are: Sca-1-APC (clone D7; eBioscience, cat. no. 17-5981-82), 1:500; Ter119-FITC (clone TER-119; eBioscience, cat. no. 11-5921-85), 1:250; CD31-FITC (clone 390; eBioscience, cat. no. 11-0311-85), 1:250; CD45-FITC (clone 30-F11; eBioscience, cat. no. 11-0451-85), 1:250; CD49f-PE (clone eBioGoH3; eBioscience, cat. no. 12-0495-83) 1:333. Cells were sorted using a FACS AriaII cytometer (BD Biosciences), and analysis of flow cytometry data was performed using FlowJo Software (Treestar). Following FACS, isolated cells were centrifuged at 500g for 5 min. The pellet was washed in PBS, homogenized in lysis buffer from the RNAqueous-Micro RNA Isolation Kit (Ambion AM1931) and the mirVana miRNA Isolation Kit (Ambion AM1560), and RNA was extracted following the kit instructions. DOI: 10.1038/ncb3057
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Stromal cell culture and Hgf ELISA. FACS-isolated stromal cells were cultured in 10% FBS/DMEM in a 48-well tissue culture plate. When the cells were 80% confluent, old medium was removed and cells were incubated in 150 µl 10% FBS/DMEM containing 10 µM purmorphamine (Calbiochem 540220) or DMSO control. In separate experiments, cultured stromal cells were treated with 10% FBS/DMEM containing 5 µg ml −1 recombinant Ihh protein (R&D 1705-HH-025) in 0.1% BSA or a BSA-only control. In separate experiments, cells were transfected with miRNA mimics for miR-26a (Ambion, Assay MC10249) or miR-26b (Ambion, Assay MC12899) or a negative control (Ambion 4464076). After 22 h, medium was removed and centrifuged at 10,000g for 5 min. To measure the concentration of Hgf in the media, 10 µl of the supernatant was used in each well of the Mouse/Rat HGF Quantikine ELISA Kit (R&D Systems, MHG00) and the plate was processed according to the manufacturer's instructions. Each sample was analysed in duplicate.
Protein extraction from prostate lobes. Individual prostate lobes were dissected in PBS, washed, and homogenized in PBS using a pestle. An equal volume of Lysis Buffer 2 (R&D 895347) was added and the homogenate was incubated at room temperature for 30 min with agitation. The lysate was centrifuged at 10,000g for 30 min at 4 • C, and the supernatant was removed. Protein levels in each extract were determined using the Quick Start Bradford 1x Dye Reagent (Bio-Rad 500-0205), equal amounts of total protein were loaded into each well of the Mouse/Rat HGF Quantikine ELISA Kit (R&D Systems, MHG00) and the plate was processed according to the manufacturer's instructions. Each sample was analysed in duplicate, and Hgf levels for each sample were normalized to total protein in each well.
Quantitative rtPCR. Prostate lobes were dissected in RNase-free PBS, and placed immediately in lysis buffer from the mirVana miRNA Isolation Kit (Ambion AM1560) or RNeasy Plus Mini Kit (Qiagen 74134). Cells were homogenized in lysis buffer using a pestle, and RNA was extracted following respective kit instructions. Colon and bladder samples were snap-frozen in liquid nitrogen, homogenized using a mortar and pestle, and RNA was extracted using the RNeasy Plus Mini Kit (Qiagen). For quantitative rtPCR of mRNA transcripts, first-strand cDNA was made using SuperScript III First-Strand Synthesis SuperMix (Invitrogen 18080-400). Quantitative rtPCR was performed using iQ SYBR Green Supermix (Bio-Rad 170-8880) and the Bio-Rad iCycler. All assay values were normalized to the HPRT1 internal control.
For quantitative rtPCR of mature miRNA, cDNA was made using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) and primers from respective TaqMan MicroRNA Assays according to the manufacturer's instructions. Quantitative rtPCR was performed using the TaqMan Universal PCR Master Mix (Applied Biosystems 4324018), TaqMan MicroRNA Assays for miR-26a (Applied Biosystems, Assay 000405) or miR-26b (Applied Biosystems, Assay 000407) or Sno202 (Applied Biosystems, Assay 001232) and the Applied Biosystems 7300 Real-Time PCR System. All assay values were normalized to the Sno202 internal control.
Conditioned medium from NIH 3T3 fibroblasts. Conditioned medium was prepared by incubating 100% confluent NIH 3T3 fibroblasts (ATCC) with 5% BCS containing 10 µM purmorphamine (Calbiochem 540220) or DMSO control. After 72 h, medium was collected and passed through a 0.22 µm filter to remove cell debris. 3T3 cells were washed in PBS and RNA was extracted using the RNeasy Plus Mini Kit (Qiagen).
MDCK tubulogenesis. Madin-Darby canine kidney (MDCKII) cells (ATCC) were
mixed with 170 µl ice-cold Geltrex Matrix (Gibco A1413201), layered onto 12mm Transwell clear filters and allowed to solidify at 37 • C. Pre-warmed DMEM containing 10% FBS was added above and below the wells. Medium was changed every 3 d. When cysts were formed (7 d after plating), tubulogenesis was induced using a 1:1 mix of 5% FBS and conditioned media from NIH 3T3 cells treated with DMSO or purmorphamine. Medium was changed daily, and cysts were analysed after 6 d. The percentage of cysts that formed extensions in 10 fields of view per well was determined, and 4 wells were analysed for each type of conditioned medium. For staining of the cysts, cysts were recovered from the Geltrex Matrix by incubating in Cell Recovery Solution (BD Biosciences 354253) on ice for 1 h. After centrifugation at 300g for 5 min, the pellet containing the cysts was washed with PBS and fixed with 4% paraformaldehyde for 20 min at 22 • C. After washing in PBS, cysts were stained with Alexa Fluor 594 phalloidin (Invitrogen A12381, 1:25) and DAPI in 10% goat serum in PBS containing 2% BSA and 0.25% Triton X-100 at 4 • C overnight. Cysts were washed in PBS containing 0.25% Triton X-100 three times and mounted on slides in Cytoseal mounting reagent (Thermo Scientific 23-244257). Immunofluorescence images presented are images from one representative experiment of three.
Confocal microscopy. Immunofluorescence images were obtained using a Zeiss LSM 510 inverted confocal microscope and prepared for publication with Zeiss LSM 5 Image Browser software and Adobe Photoshop CS4.
Generation of miRNA target reporter constructs. The full-length 3 UTR of Hgf
(corresponding to position 2310-2755 of the RefSeq sequence NM_010427) and both fragments of 3 UTR each containing a putative miR-26a/b target sequence (corresponding to positions 2363-2428 and 2508-2588 of the RefSeq sequence NM_010427) were amplified by PCR using cDNA from adult murine prostate cells as a template and primers that introduced a SpeI and HindIII cut site at the 5 and 3 end of the PCR product respectively. Each PCR product was inserted downstream of the luciferase gene in the pMir-Report vector using the SpeI and HindIII cut sites. All products were sequenced. Mutation of the putative miR-26a/b target sequence within the 3 UTR of Hgf was generated using the QuikChange Site-Directed Mutagenesis kit (Stratagene).
Luciferase reporter assays. HEK293S cells were seeded at 1 × 10 5 cells per well in 24-well plates the day before transfection. All transfections were carried out with Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. Cells were transfected with 80 ng of pMir-Report luciferase expression construct containing the 3 UTR of murine Hgf, 20 ng pRL-SV40 Renilla luciferase vector (Promega E2231) and 100 nM miR-26a mirVana miRNA mimic (Ambion, Assay MC10249) or miR-26b mimic (Ambion, Assay MC12899) or negative control miRNA mimic (Ambion 4464076). Twenty-four hours after transfection, luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega) and normalized to Renilla luciferase activity. All experiments were performed in triplicate.
In vitro tubulogenesis assay. Adult prostates from WT or R26 mTmG mice were collected, dissociated, mixed with neutralized collagen (BD Biosciences), plated out in 48-well plates (5 × 10 4 cells per well), and 500 µl of PrEGM (Lonza) was added. Medium was changed after 3 days. Five days from the start of culture, PrEGM was replaced with PrEBM (Lonza) containing hydrocortisone (5 µg ml −1 ) and insulin/transferrin/selenium (Gibco) with or without Hgf (50 ng ml −1 ). Medium was changed after 3 days and cells were imaged the following day. One representative experiment of three is presented.
In vitro cell proliferation assay. Adult prostates from WT were collected, dissociated and plated out in 96-well plates (10 4 cells per well), and 500 µl of PrEGM (Lonza) was added. After 3 days, PrEGM was replaced with PrEBM (Lonza) containing hydrocortisone (5 µg ml −1 ) and insulin/transferrin/selenium (Gibco) with or without Hgf (50 ng ml −1 ). Cells were imaged after 3 days. To quantify the number of cells in each well, cells were trypsinized and counted using a haemocytometer.
Subrenal capsule prostate grafts. Subrenal capsule graft experiments were performed as previously described 20 . Briefly, adult prostates from R26 mTmG mice were collected, dissociated, and basal and luminal cells were isolated by FACS. Urogenital sinus mesenchyme (UGSM) was collected from E16.5 embryos, passaged twice in vitro, and then infected with lentivirus expressing Hgf-IRES-GFP. Twentyfour hours after infection, UGSM were washed, trypsinized, and GFP-positive and GFP-negative cells were isolated by FACS. For the control grafts, 2 × 10 5 GFPnegative cells were combined with a total of 2 × 10 5 basal and luminal cells in equal proportion in neutralized collagen. For experimental grafts, 10 5 GFP-negative and 10 5 GFP-positive UGSM were combined with a total of 2 × 10 5 basal and luminal cells in equal proportion. Grafts were implanted into the renal capsule of anaesthetized SCID/SCID mice and a testosterone pellet (Innovative Research of America, 12.5 mg) was inserted subcutaneously. Grafts were collected 8 weeks later for analysis. One representative experiment of two is presented. 
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